231 related articles for article (PubMed ID: 14609564)
1. The effect of TGF-beta2 on human trabecular meshwork extracellular proteolytic system.
Fuchshofer R; Welge-Lussen U; Lütjen-Drecoll E
Exp Eye Res; 2003 Dec; 77(6):757-65. PubMed ID: 14609564
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells.
Fuchshofer R; Yu AH; Welge-Lüssen U; Tamm ER
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):715-26. PubMed ID: 17251470
[TBL] [Abstract][Full Text] [Related]
3. TGF-β2-induced invadosomes in human trabecular meshwork cells.
Han H; Kampik D; Grehn F; Schlunck G
PLoS One; 2013; 8(8):e70595. PubMed ID: 23940598
[TBL] [Abstract][Full Text] [Related]
4. The effect of TGF-beta2 on elastin, type VI collagen, and components of the proteolytic degradation system in human optic nerve astrocytes.
Neumann C; Yu A; Welge-Lüssen U; Lütjen-Drecoll E; Birke M
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1464-72. PubMed ID: 18385064
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells.
Junglas B; Yu AH; Welge-Lüssen U; Tamm ER; Fuchshofer R
Exp Eye Res; 2009 Jun; 88(6):1065-75. PubMed ID: 19450452
[TBL] [Abstract][Full Text] [Related]
6. Cellular fibronectin expression in human trabecular meshwork and induction by transforming growth factor-β2.
Medina-Ortiz WE; Belmares R; Neubauer S; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6779-88. PubMed ID: 24030464
[TBL] [Abstract][Full Text] [Related]
7. Elasticity-dependent modulation of TGF-β responses in human trabecular meshwork cells.
Han H; Wecker T; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2889-96. PubMed ID: 21282571
[TBL] [Abstract][Full Text] [Related]
8. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro.
Flügel-Koch C; Ohlmann A; Fuchshofer R; Welge-Lüssen U; Tamm ER
Exp Eye Res; 2004 Nov; 79(5):649-63. PubMed ID: 15500824
[TBL] [Abstract][Full Text] [Related]
10. Effects of TGF-β2 on cadherins and β-catenin in human trabecular meshwork cells.
Wecker T; Han H; Börner J; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6456-62. PubMed ID: 24003087
[TBL] [Abstract][Full Text] [Related]
11. Role of ID Proteins in BMP4 Inhibition of Profibrotic Effects of TGF-β2 in Human TM Cells.
Mody AA; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):849-859. PubMed ID: 28159972
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling.
Fuchshofer R; Stephan DA; Russell P; Tamm ER
Exp Eye Res; 2009 Jun; 88(6):1020-32. PubMed ID: 19450457
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6-mediated trans-signaling inhibits transforming growth factor-β signaling in trabecular meshwork cells.
Inoue-Mochita M; Inoue T; Kojima S; Futakuchi A; Fujimoto T; Sato-Ohira S; Tsutsumi U; Tanihara H
J Biol Chem; 2018 Jul; 293(28):10975-10984. PubMed ID: 29752408
[TBL] [Abstract][Full Text] [Related]
14. Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta1 and TGF-beta2.
Welge-Lüssen U; May CA; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2229-38. PubMed ID: 10892867
[TBL] [Abstract][Full Text] [Related]
15. TGFβ2-Hepcidin Feed-Forward Loop in the Trabecular Meshwork Implicates Iron in Glaucomatous Pathology.
Ashok A; Chaudhary S; Kritikos AE; Kang MH; McDonald D; Rhee DJ; Singh N
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):24. PubMed ID: 32182331
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta2 utilizes the canonical Smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells.
Tovar-Vidales T; Clark AF; Wordinger RJ
Exp Eye Res; 2011 Oct; 93(4):442-51. PubMed ID: 21722634
[TBL] [Abstract][Full Text] [Related]
17. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta.
Zhao X; Ramsey KE; Stephan DA; Russell P
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4023-34. PubMed ID: 15505052
[TBL] [Abstract][Full Text] [Related]
18. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure.
Fleenor DL; Shepard AR; Hellberg PE; Jacobson N; Pang IH; Clark AF
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):226-34. PubMed ID: 16384967
[TBL] [Abstract][Full Text] [Related]
19. Human trabecular meshwork cells express BMP antagonist mRNAs and proteins.
Tovar-Vidales T; Fitzgerald AM; Clark AF
Exp Eye Res; 2016 Jun; 147():156-160. PubMed ID: 27167364
[TBL] [Abstract][Full Text] [Related]
20. Effects of transforming growth factor-β2 on myocilin expression and secretion in human primary cultured trabecular meshwork cells.
Wu Y; Chen W; Guo M; He Q; Hu Y
Int J Clin Exp Pathol; 2014; 7(8):4827-36. PubMed ID: 25197353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
